Bull case
CGNX would need investors to value it at roughly 51x earnings — about 7x more generous than today's 45x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where CGNX stock could go
CGNX would need investors to value it at roughly 51x earnings — about 7x more generous than today's 45x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 39x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 20x multiple contraction could push CGNX down roughly 45% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Cognex Corporation is a machine vision technology company that provides systems and software to automate manufacturing and distribution processes through visual inspection and analysis. It generates revenue primarily from hardware sales of vision systems and sensors (~70%) and software licensing (~30%), serving industries like consumer electronics, automotive, and pharmaceuticals. The company's competitive advantage lies in its deep technical expertise, extensive patent portfolio, and established relationships with major manufacturers who rely on its reliable, high-precision vision solutions.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.25/$0.23 | +8.7% | $249M/$248M | +0.4% |
| Q4 2025 | $0.33/$0.27 | +22.2% | $277M/$239M | +15.9% |
| Q1 2026 | $0.27/$0.22 | +22.7% | $252M/$239M | +5.6% |
| Q2 2026 | $0.34/$0.25 | +36.9% | $268M/$246M | +9.1% |
CGNX beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $112 — implies +70.2% from today's price.
| Metric | CGNX | S&P 500 | Technology | 5Y Avg CGNX |
|---|---|---|---|---|
| Forward PE | 44.5x | 18.8x+137% | 22.3x+100% | — |
| Trailing PE | 97.2x | 24.4x+298% | 29.0x+235% | 52.6x+85% |
| PEG Ratio | — | 1.66x | 1.51x | — |
| EV/EBITDA | 56.1x | 15.2x+269% | 16.6x+238% | 38.0x+48% |
| Price/FCF | 46.6x | 20.7x+125% | 19.2x+143% | 47.2x |
| Price/Sales | 11.1x | 3.1x+259% | 2.4x+355% | 8.6x+28% |
| Dividend Yield | 0.49% | 1.91% | 1.11% | 0.66% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolCGNX generates $241M in free cash flow at a 23.0% margin — returns 1.9% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
Consensus target price implies limited upside potential (+8.4%) compared to current trading levels.
Rapid advancements in AI-powered machine vision solutions by competitors could erode Cognex's market share.
Projected share price fluctuations ($88.62-$92.24 by 2026) suggest uncertainty in earnings growth and market conditions.
Cognex's performance is tied to cyclical demand in industrial automation, which may slow during economic downturns.
Failure to keep pace with AI and edge computing innovations could render existing products obsolete.
While some analysts are bullish (e.g., JPMorgan upgrade), consensus targets remain conservative, indicating mixed sentiment.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
Cognex is showcasing advanced AI-powered vision systems like In-Sight® 3900 and OneVision™, combining edge AI with centralized development for smarter automation solutions.
Wall Street analysts project an 8.4% upside potential with a $70.92 consensus price target, reflecting confidence in Cognex's growth trajectory.
JPMorgan upgraded Cognex to Overweight, citing progress in AI-powered machine vision solutions and an evolving sales strategy as key growth drivers.
With 40+ years of experience, Cognex enables manufacturing efficiency through vision/barcode solutions that improve quality, traceability, and automation intelligence.
Continuous delivery of new AI vision products addresses automation challenges with high accuracy, reinforcing Cognex's technological leadership in machine vision.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
CGN CGNX Cognex Corporation | $11.0B | 44.5x | +6.7% | 13.6% | Buy | +7.3% |
KEY KEYS Keysight Technologies, Inc. | $62.4B | 35.7x | +6.5% | 17.2% | Buy | +7.1% |
COH COHU Cohu, Inc. | $3.3B | 119.3x | +3.3% | -11.5% | Buy | -28.3% |
VIA VIAV Viavi Solutions Inc. | $10.9B | 50.3x | +6.1% | -4.0% | Buy | -31.6% |
NOV NOVT Novanta Inc. | $5.5B | 43.3x | +5.8% | 5.3% | Buy | +15.9% |
KLI KLIC Kulicke and Soffa Industries, Inc. | $6.4B | 35.7x | +1.7% | 0.4% | Buy | -42.6% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
CGNX returns capital mainly through $151M/year in buybacks (1.4% buyback yield), with a modest 0.49% dividend — combining for 1.9% total shareholder yield. The dividend has grown for 10 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.17 | — | — | — |
| 2025 | $0.33 | +6.6% | 2.5% | 3.4% |
| 2024 | $0.30 | +7.0% | 1.1% | 1.9% |
| 2023 | $0.29 | +7.5% | 1.1% | 1.8% |
| 2022 | $0.27 | +8.2% | 2.5% | 3.0% |
Common questions answered from live analyst data and company financials.
Cognex Corporation (CGNX) is rated Buy by Wall Street analysts as of 2026. Of 31 analysts covering the stock, 15 rate it Buy or Strong Buy, 14 rate it Hold, and 2 rate it Sell or Strong Sell. The consensus 12-month price target is $71, implying +7.3% from the current price of $66. The bear case scenario is $36 and the bull case is $76.
The Wall Street consensus price target for CGNX is $71 based on 31 analyst estimates. The high-end target is $80 (+21.0% from today), and the low-end target is $61 (-7.7%). The base case model target is $58.
CGNX trades at 44.5x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals cheap versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for CGNX in 2026 are: (1) Competitive AI Pressure — Rapid advancements in AI-powered machine vision solutions by competitors could erode Cognex's market share. (2) Technology Disruption — Failure to keep pace with AI and edge computing innovations could render existing products obsolete. (3) Valuation Risk — Consensus target price implies limited upside potential (+8. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates CGNX will report consensus revenue of $1.1B (+6.7% year-over-year) and EPS of $1.12 (+32.8% year-over-year) for the upcoming fiscal year. The following year, analysts project $1.2B in revenue.
Cognex Corporation is expected to report its next earnings on approximately 2026-07-29. Consensus expects EPS of $0.42 and revenue of $292M. Over recent quarters, CGNX has beaten EPS estimates 92% of the time.
Cognex Corporation (CGNX) generated $241M in free cash flow over the trailing twelve months — a free cash flow margin of 23.0%. CGNX returns capital to shareholders through dividends (0.5% yield) and share repurchases ($151M TTM).